Prediction Case File
YouTubeTracking Live

You’ll remain Sidelined

2 extracted signals · 0 resolved · 2 still active

Pain of Crypto profile imagePain of CryptoIndependent analyst profile
Source published
13 Nov 2026, 22:00 UTC
Recorded by Tahlil Plus
14 Nov 2026, 00:46 UTC
Video preview for You’ll remain Sidelined
Source overview

AI-generated source summary

The speaker provides a strongly bullish macro and technical outlook for Bitcoin (BTCUSDT) following a recent market shakeout and weekly retracement, advocating for accumulation at current levels near $68,000 with a long-term target exceeding $120,000 and invalidation below $58,000. Additionally, ZCash (ZECUSDT) is briefly highlighted as a potential dip-buying opportunity near $945 based on daily chart support.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
2
Extracted from this source
Open
2
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    2 signals remain active.

Analyst snapshot

Pain of Crypto

Platform-wide history, separate from this source evaluation.

Reliability
—
Tracked signals
15
Historical success
—
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail